Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A recent study analyzes initial treatment patterns for primary membranoproliferative glomerulonephritis in Japan from 2017 to 2021, utilizing nationwide clinical records. This updated analysis provides insights into evolving therapeutic approaches for this rare kidney disease.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.